Cabaletta Bio Inc reports results for the quarter ended in March - Earnings Summary

Cabaletta Bio

12/05/2022 14:33

* Cabaletta Bio Inc  CABA.OQ  reported a quarterly adjusted
loss
of 45 cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for a loss
of 60 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Cabaletta Bio Inc's reported EPS for the quarter was a
loss
of 45 cents​.
    * The mean earnings estimate of analysts had fallen by
about 17.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Cabaletta Bio Inc shares had fallen by 39.4% this
quarter and
lost 67.5% so far this year.
    * The company reported a quarterly loss of $12.95 million.
    * Wall Street's median 12-month price target for Cabaletta
Bio Inc
is $15.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 01:32 p.m.  ​All
figures in US dollars unless otherwise stated